![Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)](https://publinestorage.blob.core.windows.net/b19a48f4-4061-46e6-b55c-8231ba2180a0/jcth-9-939-ga.jpg)
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
![Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)](https://pub.mdpi-res.com/cells/cells-08-00845/article_deploy/html/images/cells-08-00845-ag.png?1566927131)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
![American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/233adcd5-8549-4257-a3be-6b1ae68683ca/gr3_lrg.jpg)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g002.png?1644571167)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75227-x/MediaObjects/41598_2020_75227_Fig1_HTML.png)
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports
![Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group - Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group -](https://www.thelancet.com/cms/asset/7427f2be-26ee-4f69-87d7-ef52fd741901/gr1.jpg)
Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group -
![Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aadbc2ab-65a0-4957-8a0a-73a0e0959726/edm2177-toc-0001-m.jpg?trick=1674622158555)
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
![PDF] Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis | Semantic Scholar PDF] Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bbdb442edc38b8471252724f38b607977ba254d6/8-Table3-1.png)
PDF] Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis | Semantic Scholar
![American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/38af0df8-dbf6-4ed0-9a1f-d5dfc28ffad7/gr1_lrg.jpg)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
![EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fdb763b9-4d83-44fd-8086-d131b386d800/liv14349-fig-0001-m.jpg)
EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library
![EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | SpringerLink EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-016-3902-y/MediaObjects/125_2016_3902_Fig1_HTML.gif)
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | SpringerLink
![EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis - ScienceDirect EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815002597-gr1.jpg)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis - ScienceDirect
![EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f614bf7f7ba02d8f64417d8102642ee0b336f2c3/2-Table1-1.png)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar
![EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f614bf7f7ba02d8f64417d8102642ee0b336f2c3/11-Figure1-1.png)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar
![Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-021-00523-4/MediaObjects/41575_2021_523_Fig1_HTML.png)
Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology
![Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges. Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.](https://www.natap.org/2021/images/072521/072521-1/0725212.gif)
Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.
![Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease](https://www.frontiersin.org/files/Articles/634409/fimmu-11-634409-HTML/image_m/fimmu-11-634409-g001.jpg)
Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
![Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development](https://pub.mdpi-res.com/nutrients/nutrients-13-01442/article_deploy/html/images/nutrients-13-01442-g001.png?1619256508)
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
![Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD](https://tomwademd.net/wp-content/uploads/2022/05/fig1-7.png)
Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD
![Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome](https://f6publishing.blob.core.windows.net/b5134b38-08c5-4bc2-8995-2db839aa11e4/WJH-13-1494-g001.png)
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
![Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review | Journal of Health Reports and Technology | Full Text Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review | Journal of Health Reports and Technology | Full Text](https://services.brieflands.com/cdn/serve/315e4/c93894701ec2f4c3425fc3363856fbac27cbe6b0/jhrt-8-3-119454-i001-preview.png)